The author discloses that she is currently serving on a women's health advisory board for Watson Pharmaceuticals, for which she receives financial consideration. Watson Pharmaceuticals does not manufacture the drugs discussed in this article or any products in the same categories as the drugs discussed in this article.
New Developments in the Pharmacologic Treatment of Obesity
Article first published online: 11 FEB 2013
© 2013 AWHONN
Nursing for Women's Health
Volume 17, Issue 1, pages 53–62, February/March 2013
How to Cite
FANTASIA, H. C. (2013), New Developments in the Pharmacologic Treatment of Obesity. Nursing for Women's Health, 17: 53–62. doi: 10.1111/1751-486X.12006
- Issue published online: 11 FEB 2013
- Article first published online: 11 FEB 2013
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.